Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting

INTRODUCTION: At the time of dapagliflozin’s approval in Europe (2012) to treat patients with type 2 diabetes mellitus, concerns regarding acute liver injury and severe complications of urinary tract infection (sUTI) led to two post-authorization safety (PAS) studies of these outcomes to monitor the...

Descripción completa

Detalles Bibliográficos
Autores principales: Danysh, Heather E., Johannes, Catherine B., Beachler, Daniel C., Layton, J. Bradley, Ziemiecki, Ryan, Arana, Alejandro, Dinh, Jade, Li, Ling, Calingaert, Brian, Pladevall-Vila, Manel, Hunt, Phillip R., Chen, Hungta, Karlsson, Cecilia, Johnsson, Kristina, Gilsenan, Alicia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883309/
https://www.ncbi.nlm.nih.gov/pubmed/36583828
http://dx.doi.org/10.1007/s40264-022-01262-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883309/
https://www.ncbi.nlm.nih.gov/pubmed/36583828
http://dx.doi.org/10.1007/s40264-022-01262-4

Ejemplares similares